Windtree Therapeutics Inc Inc. (WINT) Price Performance: A Guide to Technical Indicators

Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. This year’s metric has recorded a Price decrease of -99.36%. However, over the past six months, we’ve seen a stronger performance of -90.21%. The price of WINT fallen by 99.33% over the last 30 days. And in the last five days, it has surged by 63.01%.

The stock price for Windtree Therapeutics Inc (WINT) currently stands at $1.19. The stock experienced a substantial increase in the last session, hitting $4.0 after starting at $1.19. The stock’s lowest price was $4.0 before closing at $1.05.

In terms of market performance, Windtree Therapeutics Inc had a fairly uneven. The highest value for the stock in the past year was $737.43 on 08/07/24, and the lowest value was recorded at $0.36 on 06/26/25.

52-week price history of WINT Stock

Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Windtree Therapeutics Inc’s current trading price is -99.84% away from its 52-week high, while its distance from the 52-week low is 230.56%. The stock’s price range during this period has varied between$0.36 and $737.43. The Windtree Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 19.17 million for the day, a figure considerably higher than their average daily volume of 9.78 million over last three months.

Market Capitalization vs. Financial Performance: A Comparative Study

Windtree Therapeutics Inc (WINT) has experienced a quarterly rise of 5.31% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 13.77M and boasts a workforce of 14 employees.

Combining Moving Average and Trading Volume Data for Better Market Insight

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.1894, with a change in price of -2.5800. Similarly, Windtree Therapeutics Inc recorded 7,859,634 in trading volume during the last 100 days, posting a change of -68.44%.

WINT’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look

The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for WINT stands at 0.15. Similarly, the long-term debt-to-equity ratio is also 0.05.

WINT Stock Stochastic Average

Windtree Therapeutics Inc’s raw stochastic average for the past 50 days is presently 55.33%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 55.33%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 59.49% and 64.42%, respectively.

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.